United States · FDA National Drug Code directory
NIKTIMVO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50881-047_b6b9ef2d-53cd-47c7-9ee5-c0610635d35b
- Product NDC
- 50881-047
- Form
- INJECTION
- Composition / generic term
- axatilimab-csfr
- Labeler
- Incyte Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260624
- Source listing expiry
- 20271231
Source-listed ingredients
- AXATILIMAB — 22 mg/2.2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (50881-047-18) / 2.2 mL in 1 VIAL, SINGLE-USE · 50881-047-18
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →